newdrugapprovals.org
Regeneron and Sanofi’s dupilumab gets FDA breakthrough therapy status for atopic dermatitis
// // // Regeneron Pharmaceuticals and Sanofi’s dupilumab has received breakthrough therapy designation from US Food and Drug Administration (FDA) to treat adults with moderate-to-severe atop…